BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2253193)

  • 1. Trisomy 7 may be a primary change in noninvasive transitional cell carcinoma of the bladder.
    Berrozpe G; Miró R; Caballin MR; Salvador J; Egozcue J
    Cancer Genet Cytogenet; 1990 Nov; 50(1):9-14. PubMed ID: 2253193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology.
    Babu VR; Lutz MD; Miles BJ; Farah RN; Weiss L; Van Dyke DL
    Cancer Res; 1987 Dec; 47(24 Pt 1):6800-5. PubMed ID: 3479251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.
    Matsuyama H; Bergerheim US; Nilsson I; Pan Y; Skoog L; Tribukait B; Ekman P
    Cancer Genet Cytogenet; 1994 Oct; 77(2):118-24. PubMed ID: 7954321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome change in transitional cell carcinoma of ureter.
    Sandberg AA; Berger CS; Haddad FS; Kerr D; Hecht F
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):335-40. PubMed ID: 3943051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5q deletion. The sole chromosome change in a carcinoma of the bladder.
    Atkin NB; Fox MF
    Cancer Genet Cytogenet; 1990 May; 46(1):129-31. PubMed ID: 2331676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere splitting in bladder cancer.
    Berrozpe G; Caballin MR; Miró R; Gelabert A; Egozcue J
    Hum Genet; 1990 Jul; 85(2):184-6. PubMed ID: 2370046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2).
    Bernués M; Casadevall C; Miró R; Caballín MR; Gelabert A; Egozcue J
    Cancer Genet Cytogenet; 1993 Aug; 69(1):76-7. PubMed ID: 8374907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal analysis of bladder cancer. III. Nonrandom alterations.
    Smeets W; Pauwels R; Laarakkers L; Debruyne F; Geraedts J
    Cancer Genet Cytogenet; 1987 Nov; 29(1):29-41. PubMed ID: 3311350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A squamous cell bladder carcinoma with karyotypic abnormalities reminiscent of transitional cell carcinoma.
    Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    J Urol; 1989 Aug; 142(2 Pt 1):374-6. PubMed ID: 2746756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.
    Bruch J; Wöhr G; Brüderlein S; Barbi G; Wolter H; Dixkens C; Mattfeldt T; Möller P; Paiss T; Hautmann R; Vogel W; Hameister H
    Int J Cancer; 1999 Mar; 80(6):903-10. PubMed ID: 10074925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trisomy 7 in a case of transitional cell carcinoma of the kidney.
    Vanni R; Nieddu M; Scarpa RM; Migliari R; Usai E
    Cancer Genet Cytogenet; 1989 Aug; 41(1):149-51. PubMed ID: 2766250
    [No Abstract]   [Full Text] [Related]  

  • 13. Trisomy 7 and i(5p) in a transitional cell carcinoma of the ureter.
    Gibas Z; Griffin CA; Emanuel BS
    Cancer Genet Cytogenet; 1987 Apr; 25(2):369-70. PubMed ID: 3828974
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytogenetic investigation of transitional cell carcinomas of the upper urinary tract.
    Dal Cin P; Roskams T; Van Poppel H; Balzarini P; Van den Berghe H
    Cancer Genet Cytogenet; 1999 Oct; 114(2):117-20. PubMed ID: 10549267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A possible specific chromosome change in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Pontes JE; Connolly JG; Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(3-4):229-38. PubMed ID: 3943046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer.
    Smeets W; Schapers R; Hopman A; Pauwels R; Ramaekers F
    Cancer Genet Cytogenet; 1993 Nov; 71(1):97-9. PubMed ID: 8275460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
    Bartlett JM; Watters AD; Ballantyne SA; Going JJ; Grigor KM; Cooke TG
    Br J Cancer; 1998 Jun; 77(12):2193-8. PubMed ID: 9649132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome changes in bladder cancer: clinical and other correlations.
    Sandberg AA
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):163-75. PubMed ID: 3455662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization.
    Hopman AH; Moesker O; Smeets AW; Pauwels RP; Vooijs GP; Ramaekers FC
    Cancer Res; 1991 Jan; 51(2):644-51. PubMed ID: 1985781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular cytogenetic study of bladder transitional cell carcinoma by FISH].
    Shou J; Wang M; Ma J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):36-8. PubMed ID: 11776593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.